Mainz, GermanyORGENTEC appoints John Garland Director International Sales.

John Garland has 25 years of commercial experience in the global in vitro diagnostics industry, with proven track record in developing and leading international sales teams. During his career he has worked for major international IVD companies, among them Abbott Diagnostics and Tecan.

At ORGENTEC John will contribute his extensive experience with managing teams from various cultures to further advance the company’s global business activities.

Gary Winer, president and chief executive officer at ORGENTEC Diagnostika, is glad to have gained such an experienced sales professional to lead the international commercial team: “It is a great pleasure that John has entered our team. He will help us to expand our international market presence and achieve our ambitious goals worldwide. We wish him a good start in Mainz!”

John Garland has joined ORGENTEC on November 1st: “I really look forward to working with our partners in our global business network to drive our business growth.”

About ORGENTEC

Headquartered in Mainz, Germany, ORGENTEC Diagnostika offers one of the industry’s most comprehensive portfolios in autoimmune diagnostics and cardiovascular diagnostics with additional strengths in infectious disease and organ function testing. Alegria®, the automated instrument for autoimmune and infectious disease serology enables labs to complete multiple assays and deliver faster results at minimum cost. With subsidiaries in Austria, Hungary, France, U.S. and China, as well as an established global network of distribution partners, ORGENTEC’s products are benefitting patients in over 100 countries around the world.

{text}

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.